Physicians’ knowledge about pharmacovigilance in Iraq

RMS, Muhannad; YA, Arwa

doi:10.4172/2329-6887.1000214

Cited by 2 publications

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…When looking at the totality of data collected in Tables 1, 2, 3, 4, 5, 6, and 7 one can note that none of the SRHR medicines are included in the Iraqi pharmacovigilance system for quality control. Even though Iraq has a spontaneous pharmacovigilance reporting system, active (mandatory) pharmacovigilance is lagging [34]. Such a gap would need to be filled and a swift and urgent collaboration between the Iraqi Pharmacovigilance Center and the SRHR-specialized healthcare institutions should be pursued to ultimately ensure an effective and safe medicine at the same time.…”

Section: Situation Of Medicines Required For Newborn Carementioning

confidence: 99%

Essential medicine required for national SRHR guidelines implementation in Iraq

Al-Kinani¹

2021

J Adv Pharm Educ Res

View full text Add to dashboard Cite

Section: Situation Of Medicines Required For Newborn Carementioning

confidence: 99%

Essential medicine required for national SRHR guidelines implementation in Iraq

Al-Kinani¹

2021

J Adv Pharm Educ Res

View full text Add to dashboard Cite

Pharmacovigilance Safety Monitoring in Clinical Trials

Nikam¹,

Jambhulkar²,

Kayande³

et al. 2021

IJPSRR

View full text Add to dashboard Cite

Pharmacovigilance is that the science and activities associated with the gathering, detection and assessment of adverse event data. Major purpose of pharmacovigilance is to gauge the benefit- risk profile of drug for better efficacy and safety to be used in patients. Pharmacovigilance plays a major role in rationale use of drug which provides the information about the adverse drug reactions which seen in patients. In terms of volume Indian Pharma industry is third largest in world and in terms of value id thirteen largest in world. India is also known as a hub for clinical research and drug development. There is a requirement of a global and standardized pharmacovigilance system in India for better safety assessment in India. In drug development process the only priority of clinical trials is to make sure patient safety during and after the trials. A critical component throughout the drug development life-cycle is monitoring patient safety. Patient must be treated consistent with the requirements and illness of patient therefore the utmost value is given to monitoring of patient safety in the least levels of drug development. Such monitoring may be a dynamic process so to approach safety monitoring. To ensure a systematic approach to safety monitoring pharmaceutical sponsor must work proactively and collaboratively with all stakeholders. We have to focus upon all the aspects of drug safety in clinical trials including basics of drug safety, regulatory aspects of drug safety, patient suitability for safety in trials, post marketing safety and causality risk assessment of the drug products.

show abstract

Physicians’ knowledge about pharmacovigilance in Iraq

Cited by 2 publications

References 17 publications

Essential medicine required for national SRHR guidelines implementation in Iraq

Essential medicine required for national SRHR guidelines implementation in Iraq

Pharmacovigilance Safety Monitoring in Clinical Trials

Contact Info

Product

Resources

About